Stans Drugs INC

Stans Drugs INC was paid $550K by Medicaid between Jan 2018 and Apr 2022, across 4 billing codes. Its largest line is A9276, Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply — 77% of everything it billed.

33Billing provider infoSTANS DRUGS INC
OXNARD, CA 93033

33aNPI1457430092assigned 11/03/2006

33bProvider typePharmacy

28Total paid$550K

24GClaims2,713

24DCodes billed4

24AFirst – last monthJan 2018 – Apr 2022

Compared with peers

Next to other Pharmacy providers in California

Rank by total paid#18 of 179

Median peer was paid$2K

This provider vs. median312×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	521	$2K
2019	142	$17K
2020	629	$161K
2021	1,070	$276K
2022	351	$95K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
A9276	Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply	77%	1,684	1,585	$427K
A9277	Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system	22%	426	425	$121K
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	<1%	371	362	$2K
A4259	Lancets, per box of 100	<1%	232	229	$182.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKARANDISH, ALI (OWNER / PIC)